{"disease":{"id":"wilson-s-disease","name":"Wilson's disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"trientine","indication_name":"Wilson's Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Syprine","generic_name":"TRIENTINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 14","drug_class":"Copper Chelator","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"trientine","indication_name":"Wilson's Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Syprine","generic_name":"TRIENTINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 14","drug_class":"Copper Chelator","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"trientine","indication_name":"Wilson's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Syprine","generic_name":"TRIENTINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 14","drug_class":"Copper Chelator","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"penicillamine","indication_name":"Wilson's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cuprimine","generic_name":"PENICILLAMINE","company_name":"Valeant Pharms Intl","drug_phase":"marketed","molecular_target":"","drug_class":"Antirheumatic Agent [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"zinc-acetate","indication_name":"Wilson's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Galzin","generic_name":"ZINC ACETATE","company_name":"Eton","drug_phase":"marketed","molecular_target":"","drug_class":"zinc acetate","quality_score":37,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT04212195","title":"Cohort Research on Wilson's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03957720","title":"The Individual Therapy for Patients With Wilson's Disease","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06573723","title":"Institutional Registry of Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT05305872","title":"Gandouling in the Treatment of Wilson's Disease","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Jun Li","has_results":false},{"nct_id":"NCT05004701","title":"Impact of the Lockdown Due to the COVID Pandemic in French Wilson's Disease Patients","phase":"","overall_status":"TERMINATED","enrollment_count":120,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT07462026","title":"Exchangeable and Relative Exchangeable Copper as an Alternative to 24-Hour Urinary Copper in Wilson's Disease Monitoring","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT07241832","title":"Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04909346","title":"Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson Disease","phase":"","overall_status":"TERMINATED","enrollment_count":51,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT06051734","title":"Early Detection of Cardiac Affection in Patients of Wilson's Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03299829","title":"A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Excelsior","has_results":false},{"nct_id":"NCT07208565","title":"Endocrine Dysfunction in Pediatric Wilson's Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06128954","title":"Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Orphalan","has_results":true},{"nct_id":"NCT07476417","title":"Oral Health, Dento-facial Condition and OHRQoL in Subjects With Mowat-Wilson Syndrome: an Epidemiologic Study.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"University of Milan","has_results":false},{"nct_id":"NCT07010575","title":"Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Orphalan","has_results":false},{"nct_id":"NCT04537377","title":"A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4,"lead_sponsor_name":"Vivet Therapeutics SAS","has_results":true}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}